These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 15307869

  • 1. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.
    Verma S, Gunuwan B, Mendler M, Govindrajan S, Redeker A.
    Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869
    [Abstract] [Full Text] [Related]

  • 2. Effects of serum aspartate aminotransferase levels in patients with autoimmune hepatitis influence disease course and outcome.
    Al-Chalabi T, Underhill JA, Portmann BC, McFarlane IG, Heneghan MA.
    Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1389-95; quiz 1287. PubMed ID: 18840547
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High aspartate to alanine aminotransferase ratio is an indicator of cirrhosis and poor outcome in patients with primary sclerosing cholangitis.
    Nyblom H, Nordlinder H, Olsson R.
    Liver Int; 2007 Jun; 27(5):694-9. PubMed ID: 17498256
    [Abstract] [Full Text] [Related]

  • 12. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.
    Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ.
    Hepatology; 2005 Jul; 42(1):53-62. PubMed ID: 15954109
    [Abstract] [Full Text] [Related]

  • 13. Consequences of treatment withdrawal in type 1 autoimmune hepatitis.
    Montano-Loza AJ, Carpenter HA, Czaja AJ.
    Liver Int; 2007 May; 27(4):507-15. PubMed ID: 17403191
    [Abstract] [Full Text] [Related]

  • 14. Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis.
    Miyake Y, Iwasaki Y, Terada R, Takagi S, Okamaoto R, Ikeda H, Sakai N, Makino Y, Kobashi H, Takaguchi K, Sakaguchi K, Shiratori Y.
    J Hepatol; 2005 Dec; 43(6):951-7. PubMed ID: 16143423
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predictors of poor outcome in patients w ith autoimmune hepatitis: a population-based study.
    Ngu JH, Gearry RB, Frampton CM, Stedman CA.
    Hepatology; 2013 Jun; 57(6):2399-406. PubMed ID: 23359353
    [Abstract] [Full Text] [Related]

  • 17. Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience.
    Kanzler S, Löhr H, Gerken G, Galle PR, Lohse AW.
    Z Gastroenterol; 2001 May; 39(5):339-41, 344-8. PubMed ID: 11413913
    [Abstract] [Full Text] [Related]

  • 18. Remission in autoimmune hepatitis: what is it, and can it ever be achieved?
    Al-Chalabi T, Heneghan MA.
    Am J Gastroenterol; 2007 May; 102(5):1013-5. PubMed ID: 17489784
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.